Selective
Minimally Invasive Treatment of
Solid Tumors

The CAPS Medical™ solution PlasmaSure™ uses Non-thermal Atmospheric Plasma in a minimally invasive procedure intended to treat a wide range of solid tumors.

PRECISE TUMOR TARGETING

The CAPS Medical  solution overcomes the challenges of delivering non-thermal plasma to internal organs, selectively destroying cancer cells without damaging surrounding healthy tissue. 

MARKETS

Cancer claims 9.5 million lives annually, with over 19 million new cases diagnosed each year. CAPS Medical Targets a $100B market.

APPLICATIONS

CAPS plans to apply its solution to wide range of cancer types including lung, liver, breast, gastrointestinal, bladder, prostate and others. CAPS Medical’s solution is on track to make a profound and needed impact.

Benefits
Selectivity
Patient prognosis strongly related to preservation of healthy tissue
Key hole procedure
Disposable catheter delivered through working channel of standard minimally invasive tools
Safety
Non-thermal.
No tissue incision = no bleeding or scarring
Control
Highly consistent treatment utilizing real-time energy monitoring

Investigation device use only, not cleared for marketing in USA and ROW

Privacy Policy